CRISPR-based innovations drove $21 billion in pharmaceutical licensing deals over five years: GlobalData, ET HealthWorld
London: The pharmaceutical trade has skilled a notable uptick in licensing agreements for innovator medication incorporating clustered frequently interspaced quick ...